The clinical value of oestrogen receptor (RE) determinations in breast cancer has been established (McGuire et al., 1975;Maynard et al., 1978) and a recent study has demonstrated the further importance of quantitative measurements (Campbell et al., 1981). However, errors in measurement of receptor value may occur, as shown by inter-and intra-laboratory variation in values with samples of the same tumour (Raam et al., 1981). The inaccuracies of the conventional assay procedure have been emphasised (Poulson, 1981) yet a recent study has shown that much observed intra-and inter-laboratory variation could be attributable to factors other than assay conditions, such as heterogeneity of tumour samples (King, 1980 (Delesse, 1848;Dunnill, 1968